June 13, 2016 Journal article Closed Access

Bona, Gianni; Guidi, Carla

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://www.openaccessrepository.it/record/166376</identifier>
  <creators>
    <creator>
      <creatorName>Bona, Gianni</creatorName>
      <givenName>Gianni</givenName>
      <familyName>Bona</familyName>
      <affiliation></affiliation>
    </creator>
    <creator>
      <creatorName>Guidi, Carla</creatorName>
      <givenName>Carla</givenName>
      <familyName>Guidi</familyName>
      <affiliation></affiliation>
    </creator>
  </creators>
  <titles>
    <title>Meningococcal vaccine evolution</title>
  </titles>
  <publisher>INFN Open Access Repository</publisher>
  <publicationYear>2016</publicationYear>
  <subjects>
    <subject>Business, Management and Accounting (miscellaneous)</subject>
    <subject>Medicine (miscellaneous)</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2016-06-13</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://www.openaccessrepository.it/record/166376</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.7175/cmi.v6i2.627</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://www.openaccessrepository.it/communities/itmirror</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial 4.0</rights>
    <rights rightsURI="info:eu-repo/semantics/closedAccess">Closed Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease. A general overview of the burden of the disease and the strains prevalence in the world with the focus in particular on the Italian situation is provided in this article, together with the vaccinations developed and under evaluation.</description>
  </descriptions>
</resource>